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INTRODUCTION
 
Pseudomembranous colitis (PMC) is a severe form of Clo-
stridium difficile infection which is usually confined to rectum 
and sigmoid colon but sometimes involves ascending colon, 
making sigmoidoscopy sufficient to detect PMC.
1 It is com-
monly associated with the antibiotics such as fluoroquinolo-
nes, clindamycin, cephalosporins, and penicillins.
2 In addition, 
antitubercular (anti-TB) agent rifampin, which has broad spec-
trum of antimicrobial activity, is also known to be an uncom-
mon cause of PMC.
3,4 Like most of the usual PMC, all of the 
reported cases of rifampin-induced PMC were also observed 
in rectosigmoid colon except for one.
5 We present a case of re-
ctosigmoid sparing PMC in a patient taking anti-TB agents. 
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CASE REPORT 
An 81-year-old man was admitted to our hospital with a 30-
day history of watery diarrhea 10 times per day and general we-
akness. He was diagnosed as pulmonary tuberculosis 45 days 
before admission and was on standard anti-TB medications, 
rifampin (600 mg/day), isoniazid (300 mg/day), ethambutol 
(800 mg/day), and pyrazinamide (1,500 mg/day) since then. 
On admission, he stopped taking all anti-TB medications for 
2 weeks after 30 days on the regimen. Vital signs were stable 
and abdominal physical examination did not show abnormal 
findings except for the hyperactive bowel sounds. Laboratory 
findings showed increased leukocyte counts (white blood cell, 
21,200/mm
3; neutrophil, 90.7%) and increased inflammatory 
markers such as erythrocyte sediment rate (75 mm/hr; nor-
mal, 0-9 mm/hr) and C-reactive protein (5.14 mg/dL; normal, 
0.02-0.3 mg/dL). 
The sputum acid-fast bacteria stain was positive and the ch-
est X-ray showed patchy consolidation in the right lung field. 
Since watery diarrhea started after 15 days of anti-TB medic-
ations and continued for 30 days, anti-TB agents induced PMC 
was suspected before C. difficile toxin result was obtained. Th-
erefore, sigmoidoscopy was initially planned. When sigmoido-
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scopic examination was performed with a colonoscope, the 
sigmoid colon revealed edematous and erosive mucosa only 
(Fig. 1). Due to diarrhea-induced bowel cleansing, the colo-
noscope was able to be advanced proximally into the terminal 
ileum, which showed multiple yellowish plaques only in the 
cecal mucosa (Fig. 2). Biopsy specimen of the cecum reveal-
ed disruption of surface epithelium with an overlying mush-
room-shaped pseudomembrane which was compatible with 
the findings of PMC (Fig. 3). After colonoscopy, the stool assay 
for C. difficile toxin came out to be positive but stool culture 
for C.difficile was negative. Oral metronidazole (1,500 mg/
day) was started and anti-TB agents excluding rifampin were 
readministerd 2 days after the initiation of metronidazole. His 
symptoms improved remarkably the day after taking the me-
dications and did not recur since then. 
DISCUSSION 
PMC is a characteristic manifestation of full blown C. dif-
ficile infection, which is acquired almost exclusively in associ-
ation with the use of antimicrobials and the consequent dis-
ruption of the normal colonic flora. Various antibiotics, in-
cluding lincomycin, clindamycin, and ß-lactam compunds are 
well known causative agents of PMC. On the other hand, anti-
TB agents are uncommon cause of PMC and a few cases of an-
ti-TB agents-related PMC have been described since the 1980s.
6-9 
Although it is still controversial whether rifampin can be a 
causative agent, rifampin has been postulated to be one of the 
causes because it has antibacterial activity on a broad spec-
trum of bacteria whereas isoniazid, pyrazinamide, and eth-
ambutol do not have antibacterial activity to disturb the nor-
mal intestinal flora.
10 Besides the broad spectrum of antibac-
terial activity, frequent isolation of rifampin-resistant toxige-
nic C. difficile also implies that rifampin could be the causative 
agent.
11,12 
In the present case, given the temporal relationship between 
anti-TB medications and the onset of symptoms, it is suspect-
ed that PMC was associated with anti-TB agents. Additional-
ly, the patient’s symptoms did not recur after rechallenging the 
rest of anti-TB agents except for rifampin, which demonst-
rates that rifampin caused PMC in our case. 
The identified risk factors for PMC include advanced age, 
Fig. 1. Endoscopic findings of the sigmoid colon showing edematous and erosive mucosa.
Fig. 2. Endoscopic findings of the cecum showing multiple elevat-
ed yellow plaques.
Fig. 3. Histological view of the cecal mucosa showing mushroom-
shaped focal explosive lesions (H&E stain ×40).SY Yim et al. 
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immunocompromised state, hospitalization, and procedures 
or medications that alter the intestinal motility or flora.
13 The 
median age of rifampin-induced PMC was 59.5 years, which 
is younger than that of usual PMC patients.
4 Our patient was 
older than most of the reported cases, although he did not have 
other risk factors. Rifampin-induced PMC was also associat-
ed with moderate-to-severe liver dysfunction.
7,10,14 It is thought 
that liver dysfunction results in reduced biliary excretion of ri-
fampin, which causes high concentration of serum levels and/
or low intestinal rifampin levels.
8,14 
The clinical presentations of PMC include diarrhea, abdo-
minal pain, fever, and leukocytosis. Most patients develop 
PMC after 5 to 10 days of antibiotic treatment. However, in 
rifampin-associated PMC, the median latency period was 4 
weeks, longer than the commonly known causes of PMC,
4 
which reflects that rifampin may have less capacity to per-
turb the intestinal bacterial flora than other antibiotics such as 
ß-lactam compounds and clindamycin.
10 The latency of our 
patient’s clinical symptom was about 2 weeks, which was short-
er than that of previously reported cases.
4,15
The confirmative diagnosis of PMC is either positive stool 
culture or positive stool toxin assay for C. difficile with clini-
cal data. However, sigmoidoscopy, colonoscopy or abdominal 
computed tomography scan can provide useful diagnostic in-
formation. PMC is commonly localized to the rectum and sig-
moid colon. Thus, sigmoidoscopy is usually sufficient to detect 
typical findings of PMC such as the pseudomembrane. How-
ever, there are reports of rectal or rectosigmoid sparing PMC 
occuring in as many as 23% to 69% of patients.
16,17 Normal mu-
cosal appearance or nonspecific proctosigmoiditis may be 
the sigmoidoscopic finding but pseudomembrane can be 
found in ascending colon as occurred in our case. Therefore, 
total colonoscopy should be performed to confirm the diagno-
sis of PMC, if sigmoidoscopy is inconclusive. The test for re-
sistant strain of C. difficile is needed for the investigation of 
causative agent of PMC in a patient suspected to have rifampin-
associated PMC. In our case, however, the test for rifampin 
resistance could not be performed due to negative stool cul-
ture of C. difficile. 
Once PMC is diagnosed, it is usually treated with oral me-
tronidazole 500 mg t.i.d. or 250 mg q.i.d. for 10 days.
18 Besides 
antibiotic therapy, restoration of beneficial intestinal flora 
with probiotics may suppress the abnormal overgrowth of C. 
difficile and thus ameliorate the course of the disease. In our 
case, watery diarrhea was disappeared with metronidazole th-
erapy, although the discontinuation of all anti-TB medications 
did not affect his symptom. However, it was recently reported 
in Korea that anti-TB agents induced PMC was treated with 
maintenance of the anti-TB medications and the addition of 
both oral metronidazole and probiotics.
15
In conclusion, our case reinforces the concept that rifampin 
can be one of the causes of PMC and reveals that rifampin-
induced PMC can be presented as a localized disease with rec-
tosigmoid sparing. Thus, total colonoscopy is needed for the 
differential diagnosis in patients with severe diarrhea devel-
oping during or after anti-TB treatment, if sigmoidoscopy is 
not confirmative. 
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